Asymmetry Capital Management as of June 30, 2020
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 32 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol-myers Squibb-cvr RTS | 9.8 | $13M | 3.6M | 3.58 | |
| Arena Pharmaceuticals | 8.3 | $11M | 173k | 62.95 | |
| Global Blood Therapeutics In | 8.3 | $11M | 171k | 63.13 | |
| Sage Therapeutics (SAGE) | 6.3 | $8.2M | 197k | 41.58 | |
| Guardant Health (GH) | 6.0 | $7.8M | 96k | 81.13 | |
| Ascendis Pharma A/s - Adr (ASND) | 5.4 | $7.0M | 48k | 147.90 | |
| Nanostring Technologies (NSTGQ) | 4.9 | $6.4M | 220k | 29.35 | |
| Momenta Pharmaceuticals | 4.1 | $5.3M | 159k | 33.27 | |
| Centene Corporation (CNC) | 3.8 | $4.9M | 77k | 63.55 | |
| Cytokinetics (CYTK) | 3.7 | $4.9M | 206k | 23.57 | |
| 10x Genomics Inc Cl A (TXG) | 3.5 | $4.5M | 51k | 89.32 | |
| Avadel Pharmaceuticals Adr | 3.3 | $4.3M | 534k | 8.08 | |
| UnitedHealth (UNH) | 2.9 | $3.8M | 13k | 294.95 | |
| Fate Therapeutics (FATE) | 2.9 | $3.7M | 109k | 34.31 | |
| Ptc Therapeutics I (PTCT) | 2.9 | $3.7M | 74k | 50.74 | |
| Antares Pharma | 2.7 | $3.6M | 1.3M | 2.75 | |
| Amicus Therapeutics (FOLD) | 2.7 | $3.5M | 235k | 15.08 | |
| Bio-Rad Laboratories (BIO) | 2.2 | $2.9M | 6.4k | 451.51 | |
| Biontech Se Adr (BNTX) | 2.0 | $2.6M | 39k | 66.74 | |
| Twist Bioscience Corp (TWST) | 1.9 | $2.4M | 53k | 45.29 | |
| Leap Therapeutics | 1.4 | $1.9M | 901k | 2.09 | |
| Aimmune Therapeutics | 1.3 | $1.7M | 101k | 16.71 | |
| Magenta Therapeutics | 1.2 | $1.6M | 211k | 7.51 | |
| Bluebird Bio (BLUE) | 1.2 | $1.5M | 25k | 61.04 | |
| Marinus Pharmaceuticals | 1.1 | $1.5M | 586k | 2.54 | |
| Gritstone Oncology Ord (GRTSQ) | 1.1 | $1.5M | 223k | 6.64 | |
| Turning Point Therapeutics I | 1.1 | $1.5M | 23k | 64.58 | |
| Arcus Biosciences Incorporated (RCUS) | 1.0 | $1.3M | 51k | 24.75 | |
| Unity Biotechnology | 0.8 | $1.0M | 120k | 8.68 | |
| Nextcure (NXTC) | 0.8 | $1.0M | 49k | 21.44 | |
| Rapt Therapeutics (RAPT) | 0.8 | $1.0M | 35k | 29.03 | |
| Nucana Plc- Adr | 0.7 | $925k | 171k | 5.41 |
